Frusemide-induced nephrocalcinosis in very low birth weight infants
- 35 Downloads
Three very low birth weight infants, treated with frusemide for broncho-pulmonary dysplasia are described. They all developed medullary nephrocalcinosis identifiable by real time ultrasound. The sonographic findings of diffuse medullary hyper-echogenicity appears to be specific for nephrocalcinosis.
Unable to display preview. Download preview PDF.
- 1.Hufnagle KG, Khan SN, Penn D, Cacciarell A, Williams P (1982) Renal calcifications: a complication of long term furosemide therapy in preterm infants. Paediatrics 70: 360Google Scholar
- 6.Foley LC, Luisiri A, Graviss ER, Campbell JB (1982) Nephrocalcinosis: sonographic detection in Cushings' syndrome. Am J Roentgenol 139: 610Google Scholar
- 7.Rueter K, Klienman PK, De Witt T, Fabian T (1985) Unsuspected medullary nephrocalcinosis from furosemide administration: sonographic evaluation. JCU 13: 357Google Scholar
- 9.Glasier CM, Stoddard RA, Ackerman NB, McCurdy FA, Donald MN Jr, Delemos RA (1983) Nephrolithiasis in infants: association with chronic furosemide therapy. Am J Roentgenol 140: 107Google Scholar
- 10.Patriquin H, Robitaille P (1986) Renal calcium deposition in children: sonographic demonstration of the Anderson-Carr progression. Am J Roentgenol 146: 1253Google Scholar